To hear about similar clinical trials, please enter your email below
Trial Title:
Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
NCT ID:
NCT05864976
Condition:
Glioblastoma Multiforme
Conditions: Official terms:
Glioblastoma
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Device
Intervention name:
Support Vector Machine
Description:
Machine learning algorithm
Arm group label:
Standard of care rsfMRI using the Support Vector Machine algorithm
Summary:
This study is investigating the use of a computer algorithm to analyze scans of the brain
before surgery to predict how a person's tumor will respond to treatment.
Criteria for eligibility:
Study pop:
Participants being seen at Washington University School of Medicine.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Must have a radiological diagnosis of a lesion in the brain with characteristics
consistent with glioblastoma multiforme.
- Must be planning to undergo a pre-operative MRI.
- Must be at least 18 years old.
- Must be able to understand and willing to sign an IRB approved written informed
consent document.
Exclusion Criteria:
- Contraindication to MRI.
- Inability to have clinical follow-up (e.g., patient is out of town and will do
follow-up elsewhere).
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Washington University School of Medicine
Address:
City:
Saint Louis
Zip:
63110
Country:
United States
Status:
Recruiting
Contact:
Last name:
Dimitrios Mathios, M.D.
Phone:
314-747-6146
Email:
mathios@wustl.edu
Investigator:
Last name:
Dimitrios Mathios, M.D.
Email:
Principal Investigator
Investigator:
Last name:
Joshua Shimony, M.D.
Email:
Sub-Investigator
Investigator:
Last name:
Milan Chheda, M.D.
Email:
Sub-Investigator
Investigator:
Last name:
Abraham Synder, M.D., Ph.D.
Email:
Sub-Investigator
Investigator:
Last name:
Patrick Luckett, Ph.D.
Email:
Sub-Investigator
Investigator:
Last name:
Feng Gao, Ph.D.
Email:
Sub-Investigator
Investigator:
Last name:
Eric Leuthardt, M.D.
Email:
Sub-Investigator
Start date:
December 6, 2023
Completion date:
January 31, 2030
Lead sponsor:
Agency:
Washington University School of Medicine
Agency class:
Other
Collaborator:
Agency:
National Cancer Institute (NCI)
Agency class:
NIH
Source:
Washington University School of Medicine
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05864976
http://www.siteman.wustl.edu
